Results 31 to 40 of about 106,571 (324)

The effect of Midazolam and Propranolol on fear memory reconsolidation in ethanol-withdrawn rats: Influence of D-cycloserine [PDF]

, 2014
Background: Withdrawal from chronic ethanol facilitates the formation of contextual fear memory and delays the onset to extinction, with its retrieval promoting an increase in ethanol consumption.
Espejo, Pablo Javier, Giachero, Marcelo, Martijena, Irene Delia, Molina, Víctor Alejandro, Ortiz, Vanesa   +4 more
core   +1 more source

Involvement of propranolol in suicides: cross-sectional study using coroner-reported data

BJPsych Open
Background Propranolol is a beta-blocker medication indicated mostly for heart rhythm conditions and for physical symptoms of anxiety. Prescriptions for propranolol in the UK have increased since 2008.
Hayley C. Gorton, Charlotte Archer, Thikra Algahtani, Faraz Mughal, Caroline S. Copeland   +4 more
doaj   +1 more source

The use of non-selective beta-blockers in patients with cirrhosis: more doubts than certainties [PDF]

, 2017
In conclusion, prospective RCT would be needed on the use of NSBBs in decompensated cirrhotic patients with ascites however these trials are difficult to organize and will need a large sample size.
Di Gregorio, Vincenza, D’Ambrosio, Daria, Lattanzi, Barbara, Merli, Manuela   +3 more
core   +1 more source

Propranolol in Treatment of Huge and Complicated Infantile Hemangiomas in Egyptian Children

Dermatology Research and Practice, 2014
Background. Infantile hemangiomas (IHs) are the most common benign tumours of infancy. Propranolol has recently been reported to be a highly effective treatment for IHs.
Basheir A. Hassan, Khalid S. Shreef
doaj   +1 more source

Deep coma in a child treated with propranolol for infantile hemangioma

BMC Pediatrics, 2019
Background Propranolol hydrochloride is the first-line agent recommended for the treatment of infantile hemangiomas (IH). Serious adverse effects of propranolol therapy for hemangiomas are infrequent.
Ilirjana Bakalli, Elmira Kola, Robert Lluka, Ermela Celaj, Durim Sala, Inva Gjeta, Sashenka Sallabanda, Dea Klironomi   +7 more
doaj   +1 more source

The impact of propranolol on nitric oxide and total antioxidant capacity in patients with resistant hypertension—evidence from the APPROPRIATE trial

BMC Research Notes, 2020
Objectives The objective was to assess the effect of propranolol on oxidative stress and anti-oxidant potential in patients with resistant hypertension as a secondary analysis of the APPROPRIATE trial.
H. N. Ranasinghe, N. Fernando, S. Handunnetti, P. N. Weeratunga, P. Katulanda, S. Rajapakse, P. Galappatthy, G. R. Constantine   +7 more
doaj   +1 more source

Neutral‐pH Electropolymerization of Aniline on Hierarchically Porous Laser‐Induced Graphene Electrodes for Dual Biosensing

Advanced Materials Technologies, EarlyView.
Neutral‐pH electropolymerization of aniline on laser‐induced graphene (LIG) produces stable, brush‐like polyaniline coatings without requiring acidic conditions. The resulting PANI–LIG electrodes exhibit enhanced electroactive surface area, efficient charge transfer, and dual sensing capability for β‐blockers and pH, providing a scalable platform ...
Angelika Łepek, Aiswarya Manohar, Mattia Pierpaoli, Robert Bogdanowicz, Łukasz Gaweł, Mohsen Khodadadi Yazdi, Jacek Ryl   +6 more
wiley   +1 more source

Lactylation‐Driven YTHDC1 Alleviates MASLD by Suppressing PTPN22‐Mediated Dephosphorylation of NLRP3

Advanced Science, EarlyView.
In MASLD, YTHDC1 undergoes increased lactylation and ubiquitination, reducing its expression. AARS1 mediates lactylation at lysine 565, while disrupted binding to LDHA further promotes lactylation, suppressing YTHDC1. This downregulation enhances PTPN22 mRNA stability, leading to NLRP3 dephosphorylation and activation, which exacerbates inflammation ...
Feng Zhang, Linghua Zeng, Kunkun Zou, Keying Lin, Fangting Yao, Jinglun Song, Shumeng Zhang, Hanshu Feng, Zhichao Yang, Chunlei Wang, Hongtao Diao, Xue Kong, Tengfei Pan, Joonki Kim, Tianqi Duo, Linqiang Li, Yu Bian   +16 more
wiley   +1 more source

Propranolol: A 50-year historical perspective

Annals of Indian Academy of Neurology, 2019
Propranolol is a beta-adrenergic receptor antagonist that was developed by the British scientist Sir James Black primarily for the treatment of angina pectoris, more than 50 years ago.
A V Srinivasan
doaj   +1 more source

On the Blameworthiness of Forgetting [PDF]

, 2018
It is a mistake to think that we cannot be morally responsible for forgetting because, as a matter of principle, forgetting is outside of our control. Sometimes we do have control over our forgetting.
Bernecker, Sven
core   +1 more source